Outcome of suicidal patients with schizophrenia: Results from a naturalistic study

Acta Psychiatrica Scandinavica

Volumn 121, Issue 5, 2010, Pages 359-370

  Schennach Wolff, R ^a   Jager M ^a   Seemuller F ^a   Obermeier, M ^a   Schmauss, M ^b   Laux, G ^c   Pfeiffer, H ^d   Naber, D ^e   Schmidt, L G ^f   Gaebel, W ^g   Klosterkotter J ^h   Heuser, I ⁱ   Maier, W ^j   Lemke, M R ^k   Ruther E ^l   Klingberg, S ^m   Gastpar, M ⁿ   Moller H J ^a   Riedel, M ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b District Hospital Augsburg   (Germany)

^c Inn Salzach Hospital Wasserburg/Inn   (Germany)

^d KLINIKUM MÜNCHEN OST   (Germany)

^e UNIVERSITY OF HAMBURG   (Germany)

^f JOHANNES GUTENBERG UNIVERSITY   (Germany)

^g HEINRICH HEINE UNIVERSITY   (Germany)

^h UNIVERSITY OF COLOGNE   (Germany)

ⁱ CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^j UNIVERSITY OF BONN   (Germany)

^k Alsterdorf Hospital   (Germany)

^l UNIVERSITY OF GÖTTINGEN   (Germany)

^m UNIVERSITY OF TÜBINGEN   (Germany)

ⁿ UNIVERSITY OF DUISBURG ESSEN   (Germany)

more..

Author keywords

Insight into illness; Remission; Response; Schizophrenia; Suicidality

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HAMILTON SCALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MALE; MENTAL PATIENT; NATURALISTIC INQUIRY; OUTCOME ASSESSMENT; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; REMISSION; SCHIZOPHRENIA; SCORING SYSTEM; SUICIDE;

ACUTE DISEASE; ADULT; AKATHISIA, DRUG-INDUCED; ANTIPSYCHOTIC AGENTS; COHORT STUDIES; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; GERMANY; HEALTH SURVEYS; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SUICIDE, ATTEMPTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77950956408     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2009.01484.x     Document Type: Article

References (66)

1. Gupta S, Black DW, Arndt S, Hubbard WC, Andreasen NC. Factors associated with suicide attempts among patients with schizophrenia. Psychiatr Serv 1998 49 : 1353 1355.
2. Addington J, Williams J, Young J, Addington D. Suicidal behaviour in early psychosis. Acta Psychiatr Scand 2004 109 : 116 120.
3. Heila H, Isometsa ET, Henriksson MM, Heikkinen ME, Marttunen MJ, Lonnqvist JK. Suicide and schizophrenia: a nationwide psychological autopsy study on age- and sex-specific clinical characteristics of 92 suicide victims with schizophrenia. Am J Psychiatry 1997 154 : 1235 1242.
4. Bleuler M. The Schizophrenic Disorders: Long-term Patient and Familiy Studies.
5. Khan A, Khan SR, Leventhal RM, Brown WA. Symptom reduction and suicide risk among patients treated with placebo in antipsychotic clinical trials: an analysis of the food and drug administration database. Am J Psychiatry 2001 158 : 1449 1454. (Pubitemid 32847244)
6. Munro J, O'Sullivan D, Andrews C, Arana A, Mortimer A, Kerwin R. Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance. Br J Psychiatry 1999 175 : 576 580.
7. Meltzer HY, Alphs L, Green AI et al. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry 2003 60 : 82 91.
8. Satcher D. From The Surgeon General. Tuberculosis - battling an ancient scourge. JAMA 1999 282 : 1996.
9. Rossau CD, Mortensen PB. Risk factors for suicide in patients with schizophrenia: nested case-control study. Br J Psychiatry 1997 171 : 355 359. 355-359
10. Modestin J, Zarro I, Waldvogel D. A study of suicide in schizophrenic in-patients. Br J Psychiatry 1992 160 : 398 401.
11. Cem AE, Schultz SK, Andreasen NC. The relationship of akathisia with suicidality and depersonalization among patients with schizophrenia. J Neuropsychiatry Clin Neurosci 2001 13 : 336 341.
12. Emsley R, Chiliza B, Schoeman R. Predictors of long-term outcome in schizophrenia. Curr Opin Psychiatry 2008 21 : 173 177.
13. Schwartz RC, Smith SD. Suicidality and psychosis: the predictive potential of symptomatology and insight into illness. J Psychiatr Res 2004 38 : 185 191.
14. Amador XF, Friedman JH, Kasapis C, Yale SA, Flaum M, Gorman JM. Suicidal behavior in schizophrenia and its relationship to awareness of illness. Am J Psychiatry 1996 153 : 1185 1188.
15. Drake RJ. Insight into illness: impact on diagnosis and outcome of nonaffective psychosis. Curr Psychiatry Rep 2008 10 : 210 216.
16. Drake RJ, Dunn G, Tarrier N, Bentall RP, Haddock G, Lewis SW. Insight as a predictor of the outcome of first-episode nonaffective psychosis in a prospective cohort study in England. J Clin Psychiatry 2007 68 : 81 86.
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders.
18. Cording C. Conceptual aspects in development and implementation of basic psychiatric documentation. Psychiatr Prax 1998 25 : 175 178.
19. Spiessl H, Hubner-Liebermann B, Cording C, Klein HE. Evidence-based hospital management considering data from the psychiatric basic documentation system. Psychiatr Prax 2004 1 : S9 S11.
20. Kay SR, Opler LA, Lindenmayer JP. Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry Res 1988 23 : 99 110.
21. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967 6 : 278 296.
22. Olden M, Rosenfeld B, Pessin H, Breitbart W. Measuring depression at the end of life: is the Hamilton Depression Rating Scale a valid instrument? Assessment 2009 16 : 43 54.
23. Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl 1987 334 : 1 100.
24. Marder SR, Meibach RC. Risperidone in the treatment of schizophrenia. Am J Psychiatry 1994 151 : 825 835.
25. Peuskens J. Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group. Br J Psychiatry 1995 166 : 712 726.
26. Andreasen NC, Carpenter WT Jr., Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 2005 162 : 441 449.
27. Altamura AC, Bassetti R, Bignotti S, Pioli R, Mundo E. Clinical variables related to suicide attempts in schizophrenic patients: a retrospective study. Schizophr Res 2003 60 : 47 55.
28. Kessler RC, Borges G, Walters EE. Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey. Arch Gen Psychiatry 1999 56 : 617 626.
29. Maris RW. Suicide. Lancet 2002 360 : 319 326.
30. Mauri MC, Cerveri G, Volonteri LS et al. Parasuicide and drug self-poisoning: analysis of the epidemiological and clinical variables of the patients admitted to the Poisoning Treatment Centre (CAV), Niguarda General Hospital, Milan. Clin Pract Epidemol Ment Health 2005 1 : 5.
31. Silverton L, Mednick SA, Holst C, John R. High social class and suicide in persons at risk for schizophrenia. Acta Psychiatr Scand 2008 117 : 192 197.
32. Gut-Fayand A, Dervaux A, Olie JP, Loo H, Poirier MF, Krebs MO. Substance abuse and suicidality in schizophrenia: a common risk factor linked to impulsivity. Psychiatry Res 2001 102 : 65 72.
33. Shoval G, Sever J, Sher L et al. Substance use, suicidality, and adolescent-onset schizophrenia: an Israeli 10-year retrospective study. J Child Adolesc Psychopharmacol 2006 16 : 767 775.
34. Shoval G, Zalsman G, Apter A, Diller R, Sher L, Weizman A. A 10-year retrospective study of inpatient adolescents with schizophrenia/schizoaffective disorder and substance use. Compr Psychiatry 2007 48 : 1 7.
35. Kim CH, Jayathilake K, Meltzer HY. Hopelessness, neurocognitive function, and insight in schizophrenia: relationship to suicidal behavior. Schizophr Res 2003 60 : 71 80.
36. Fialko L, Freeman D, Bebbington PE et al. Understanding suicidal ideation in psychosis: findings from the Psychological Prevention of Relapse in Psychosis (PRP) trial. Acta Psychiatr Scand 2006 114 : 177 186.
37. De HM, McKenzie K, Peuskens J. Risk factors for suicide in young people suffering from schizophrenia: a long-term follow-up study. Schizophr Res 2001 47 : 127 134.
38. Stephens JH, Richard P, McHugh PR. Suicide in patients hospitalized for schizophrenia: 1913-1940. J Nerv Ment Dis 1999 187 : 10 14.
39. Saarinen PI, Lehtonen J, Lonnqvist J. Suicide risk in schizophrenia: an analysis of 17 consecutive suicides. Schizophr Bull 1999 25 : 533 542.
40. Contreras J, Hare L, Camarena B et al. The serotonin transporter 5-HTTPR polymorphism is associated with current and lifetime depression in persons with chronic psychotic disorders. Acta Psychiatr Scand 2009 119 : 117 127.
41. Acosta FJ, Aguilar EJ, Cejas MR, Gracia R, Caballero-Hidalgo A, Siris SG. Are there subtypes of suicidal schizophrenia? A prospective study. Schizophr Res 2006 86 : 215 220.
42. Fenton WS, McGlashan TH, Victor BJ, Blyler CR. Symptoms, subtype, and suicidality in patients with schizophrenia spectrum disorders. Am J Psychiatry 1997 154 : 199 204.
43. Kelly DL, Shim JC, Feldman SM, Yu Y, Conley RR. Lifetime psychiatric symptoms in persons with schizophrenia who died by suicide compared to other means of death. J Psychiatr Res 2004 38 : 531 536.
44. Carpenter WT Jr., Heinrichs DW, Alphs LD. Treatment of negative symptoms. Schizophr Bull 1985 11 : 440 452.
45. Siris SG, Adan F, Cohen M, Mandeli J, Aronson A, Casey E. Postpsychotic depression and negative symptoms: an investigation of syndromal overlap. Am J Psychiatry 1988 145 : 1532 1537.
46. Andreasen NC, Olsen S. Negative v positive schizophrenia. Definition and validation. Arch Gen Psychiatry 1982 39 : 789 794.
47. Siris SG. Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents. Am J Psychiatry 2000 157 : 1379 1389.
48. Siris SG. Suicide and schizophrenia. J Psychopharmacol 2001 15 : 127 135.
49. Grunebaum MF, Oquendo MA, Harkavy-Friedman JM et al. Delusions and suicidality. Am J Psychiatry 2001 158 : 742 747.
50. Lane RM. SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment. J Psychopharmacol 1998 12 : 192 214.
51. Naber D, Moritz S, Lambert M et al. Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs. Schizophr Res 2001 50 : 79 88. (Pubitemid 32510889)
52. Vanhala M, Jokelainen J, Keinanen-Kiukaanniemi S, Kumpusalo E, Koponen H. Depressive symptoms predispose females to metabolic syndrome: a 7-year follow-up study. Acta Psychiatr Scand 2009 119 : 137 142.
53. Warnes H. Suicide in schizophrenics. Dis Nerv Syst 1968 29 (Suppl. 40 35 40.
54. Cohen S, Leonard CV, Farberow NL, Shneidman ES. Tranquilizers and suicide in the schizophrenic patient. Arch Gen Psychiatry 1964 11 : 312 321.
55. Hansen L, Wilkinson DG. Drug induced akathisia, suicidal ideation and its treatment in the elderly. Int J Geriatr Psychiatry 2001 16 : 231 233.
56. Hansen L, Jones RM, Kingdon D. No association between akathisia or Parkinsonism and suicidality in treatment-resistant Schizophrenia. J Psychopharmacol 2004 18 : 384 387.
57. Hansen L. A critical review of akathisia, and its possible association with suicidal behaviour. Hum Psychopharmacol 2001 16 : 495 505.
58. Amador XF, Strauss DH, Yale SA, Gorman JM. Awareness of illness in schizophrenia. Schizophr Bull 1991 17 : 113 132.
59. Karow A, Pajonk FG, Reimer J et al. The dilemma of insight into illness in schizophrenia: self- and expert-rated insight and quality of life. Eur Arch Psychiatry Clin Neurosci 2008 258 : 152 159.
60. Mintz AR, Addington J, Addington D. Insight in early psychosis: a 1-year follow-up. Schizophr Res 2004 67 : 213 217.
61. Iqbal Z, Birchwood M, Chadwick P, Trower P. Cognitive approach to depression and suicidal thinking in psychosis. 2. Testing the validity of a social ranking model. Br J Psychiatry 2000 177 : 522 528.
62. Whitty P, Browne S, Clarke M et al. Systematic comparison of subjective and objective measures of quality of life at 4-year follow-up subsequent to a first episode of psychosis. J Nerv Ment Dis 2004 192 : 805 809.
63. Smith TE, Hull JW, Huppert JD, Silverstein SM, Anthony DT, McClough JF. Insight and recovery from psychosis in chronic schizophrenia and schizoaffective disorder patients. J Psychiatr Res 2004 38 : 169 176.
64. Emsley R, Rabinowitz J, Medori R. Remission in early psychosis: rates, predictors, and clinical and functional outcome correlates. Schizophr Res 2007 89 : 129 139.
65. Lasser RA, Bossie CA, Gharabawi GM, Kane JM. Remission in schizophrenia: results from a 1-year study of long-acting risperidone injection. Schizophr Res 2005 77 : 215 227.
66. Sethuraman G, Taylor CC, Enerson M, Dunayevich E. A retrospective comparison of cumulative time spent in remission during treatment with olanzapine or risperidone among patients with schizophrenia. Schizophr Res 2005 79 : 337 340.